Variables | Total | <60 |  ≥ 60 |
---|---|---|---|
Age |  < 0.001 |  |  |
 <60 |  |  |  |
  ≥ 60 |  |  |  |
Year of diagnosis | 0.006 | 0.329 | 0.035 |
 1992–2002 |  |  |  |
 2003–2012 |  |  |  |
 2013–2018 |  |  |  |
Sex | 0.757 | 0.4 | 0.794 |
 Male |  |  |  |
 Female |  |  |  |
Race | 0.188 | 0.091 | 0.785 |
 White |  |  |  |
 Others |  |  |  |
Laterality | 0.05 | 0.03 | 0.072 |
 Unilateral |  |  |  |
 Bilateral |  |  |  |
 Unknown |  |  |  |
Primary site | 0.002 | 0.946 | 0.018 |
 Retina |  |  |  |
 Choroid |  |  |  |
 Ciliary body |  |  |  |
 Vitreous |  |  |  |
Pathological type |  < 0.001 | 0.347 |  < 0.001 |
 DLBCL |  |  |  |
 MALT |  |  |  |
 NHL, NOS |  |  |  |
 Other/unclassifiedb |  |  |  |
Ann arbor stage | 0.057 | 0.22 | 0.032 |
 I to II |  |  |  |
 III to IV |  |  |  |
 Unknown |  |  |  |
Surgery | 0.44 | 0.949 | 0.521 |
 No/unknown |  |  |  |
 Performed |  |  |  |
Radiotherapy | 0.361 | 0.147 | 0.715 |
 No/unknown |  |  |  |
 Performed |  |  |  |
Chemotherapy |  < 0.001 | 0.001 | 0.001 |
 No/unknown |  |  |  |
 Performed |  |  |  |